These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 16580256

  • 21. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
    Panunti B, Fonseca V.
    Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
    [Abstract] [Full Text] [Related]

  • 22. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R, Golla R, Ma Z, Zhang H, O'Malley K, Lippy J, Cheng L, Mookhtiar K, Farrelly D, Zhang L, Hariharan N, Cheng PT.
    Anal Biochem; 2007 Apr 15; 363(2):263-74. PubMed ID: 17335769
    [Abstract] [Full Text] [Related]

  • 23. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D, Yoshihiro H, Nakanishi M, Naruyama H, Okada S, Ando R, Tozawa K, Kohri K.
    Cancer Detect Prev; 2008 Apr 15; 32(3):259-66. PubMed ID: 18789607
    [Abstract] [Full Text] [Related]

  • 24. Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair.
    Standiford TJ, Keshamouni VG, Reddy RC.
    Proc Am Thorac Soc; 2005 Apr 15; 2(3):226-31. PubMed ID: 16222042
    [Abstract] [Full Text] [Related]

  • 25. Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance.
    Guo L, Tabrizchi R.
    Pharmacol Ther; 2006 Jul 15; 111(1):145-73. PubMed ID: 16305809
    [Abstract] [Full Text] [Related]

  • 26. PPAR and Pain.
    Maeda T, Kishioka S.
    Int Rev Neurobiol; 2009 Jul 15; 85():165-77. PubMed ID: 19607969
    [Abstract] [Full Text] [Related]

  • 27. Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure.
    Thiemermann C.
    Br J Pharmacol; 2004 Jan 15; 141(1):1-3. PubMed ID: 14662733
    [Abstract] [Full Text] [Related]

  • 28. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison).
    Desmarais JA, Lopes FL, Zhang H, Das SK, Murphy BD.
    Biol Reprod; 2007 Nov 15; 77(5):829-39. PubMed ID: 17615406
    [Abstract] [Full Text] [Related]

  • 29. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW.
    Ann Hematol; 2007 Mar 15; 86(3):173-83. PubMed ID: 17089125
    [Abstract] [Full Text] [Related]

  • 30. Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.
    Staumont-Sallé D, Abboud G, Brénuchon C, Kanda A, Roumier T, Lavogiez C, Fleury S, Rémy P, Papin JP, Bertrand-Michel J, Tercé F, Staels B, Delaporte E, Capron M, Dombrowicz D.
    J Allergy Clin Immunol; 2008 Apr 15; 121(4):962-8.e6. PubMed ID: 18249437
    [Abstract] [Full Text] [Related]

  • 31. Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears.
    Mao Z, Ong AC.
    Nephron Clin Pract; 2009 Apr 15; 112(4):c230-41. PubMed ID: 19546582
    [Abstract] [Full Text] [Related]

  • 32. Variations in the genes encoding the peroxisome proliferator-activated receptors alpha and gamma in psoriasis.
    Mössner R, Kaiser R, Matern P, Krüger U, Westphal GA, Brockmöller J, Ziegler A, Neumann C, König IR, Reich K.
    Arch Dermatol Res; 2004 Jun 15; 296(1):1-5. PubMed ID: 15083308
    [Abstract] [Full Text] [Related]

  • 33. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ, Usher MG, Mortensen RM.
    Circ Res; 2008 Feb 15; 102(3):283-94. PubMed ID: 18276926
    [Abstract] [Full Text] [Related]

  • 34. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O.
    Anticancer Drugs; 2006 Aug 15; 17(7):763-9. PubMed ID: 16926626
    [Abstract] [Full Text] [Related]

  • 35. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C, Tsantili-Kakoulidou A, Theocharis S.
    Fundam Clin Pharmacol; 2007 Jun 15; 21(3):231-44. PubMed ID: 17521292
    [Abstract] [Full Text] [Related]

  • 36. Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein.
    Genovese T, Mazzon E, Di Paola R, Muià C, Crisafulli C, Malleo G, Esposito E, Cuzzocrea S.
    Immunology; 2006 Aug 15; 118(4):559-70. PubMed ID: 16764691
    [Abstract] [Full Text] [Related]

  • 37. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.
    Pharmacol Rev; 2006 Dec 15; 58(4):726-41. PubMed ID: 17132851
    [Abstract] [Full Text] [Related]

  • 38. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways.
    Mei CL, He P, Cheng B, Liu W, Wang YF, Wan JJ.
    Cell Biol Int; 2009 Mar 15; 33(3):301-8. PubMed ID: 19114110
    [Abstract] [Full Text] [Related]

  • 39. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA, Piqueras L, Bishop-Bailey D.
    Pharmacol Ther; 2006 Jun 15; 110(3):371-85. PubMed ID: 16168490
    [Abstract] [Full Text] [Related]

  • 40. Therapeutical effects of PPAR agonists assessed by biomarker modulation.
    Chinetti-Gbaguidi G, Fruchart JC, Staels B.
    Biomarkers; 2005 Nov 15; 10 Suppl 1():S30-6. PubMed ID: 16298909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.